News

Deal Announcements

Achaogen Adds $19 Million Venture Capital Investment

Tuesday, March 26, 2013 5:33:00 AM PDT | VentureDeal
   South San Francisco, California  --  Biotechnology company Achaogen has garnered $18.9 million in venture capital equity financing, according to an SEC filing.

Achaogen is focused on developing small molecules to treat infections caused by bacterial infection that are especially resistant to antibiotics.

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

Achaogen is still seeking $11.8 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1